Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
- 2018 -
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
September 2018 - 52 products
IP
CI
Nevirapin Viatris 400 mg
30
162.68
193.35
10 %
Delayed release tablets: Nevirapinum 400 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
Darunavir Viatris 400 mg
60
213.57
249.15
10 %
Tablets: Darunavirum 400 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
Darunavir Viatris 600 mg
60
320.37
365.50
10 %
Tablets: Darunavirum 600 mg
Viatris Pharma GmbH
● 
A / SL / SG
FB
G
IP
Darunavir Viatris 800 mg
30
213.57
249.10
10 %
Tablets: Darunavirum 800 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
CM
SUN STORE
Dextromethorphan
200 ml
PR
PR
k.A.
Sirup: Dextromethorphanum 25 mg
Sun Store Health Care AG
B
FB
G
IP
Tadalafil Menarini 2.5 mg
28
PR
PR
k.A.
Coated tablets: Tadalafilum 2.5 mg
A. Menarini GmbH
B
FB
G
IP
Tadalafil Menarini 5 mg
28
PR
PR
k.A.
Coated tablets: Tadalafilum 5 mg
A. Menarini GmbH
B
FB
G
IP
Tadalafil Menarini 10 mg
4
PR
PR
k.A.
Coated tablets: Tadalafilum 10 mg
A. Menarini GmbH
B
FB
G
IP
CI
Tadalafil Menarini 20 mg
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
A. Menarini GmbH
B
FB
G
L
IP
CI
CM
Ondansetron ODT Sandoz 4 mg
10
22.60
40.95
10 %
Melting tablets: Ondansetronum 4 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CM
Ondansetron ODT Sandoz 8 mg
6
22.61
40.95
10 %
Melting tablets: Ondansetronum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Irinotecan Accord 40 mg/2 ml
37.53
57.25
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Irinotecan Accord 100
mg/5 ml
90.97
115.40
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Irinotecan Accord 300
mg/15 ml
245.64
283.55
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Irinotecan Accord 500
mg/25 ml
357.73
405.70
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
Accord Healthcare AG
● 
A / SL / SG
FB
G
L
IP
CI
CM
Ondansetron Sandoz 4 mg
10
20.56
38.85
10 %
Coated tablets: Ondansetronum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 8 mg
6
20.56
38.85
10 %
Coated tablets: Ondansetronum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Dutasterid Duo Spirig HC 0.5
mg/0.4 mg
7
3.71
13.25
10 %
Capsules: 2 Active Agents
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
CI
Dutasterid Duo Spirig HC 0.5
mg/0.4 mg
30
15.87
33.60
10 %
Capsules: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Dutasterid Duo Spirig HC 0.5
mg/0.4 mg
90
47.61
67.85
10 %
Capsules: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Dutasterid-Tamsulosin-
Mepha 0.5 mg/0.4 mg
7
3.71
13.25
10 %
Capsules: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Dutasterid-Tamsulosin-
Mepha 0.5 mg/0.4 mg
30
15.87
33.60
10 %
Capsules: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Dutasterid-Tamsulosin-
Mepha 0.5 mg/0.4 mg
90
47.61
67.85
10 %
Capsules: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 4 mg/2 ml
5 x 2 ml
30.88
50.00
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 4 mg/2 ml
10 x 2 ml
61.76
83.60
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 8 mg/4 ml
5 x 4 ml
57.55
79.00
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 8 mg/4 ml
8 x 4 ml
92.08
116.55
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Benepali 50 mg
2
368.63
417.30
10 %
Injection solution in prefilled syringe: Etanerceptum 50 mg/ml
Samsung Bioepis CH
GmbH
B / SL
FB
G
L
IP
CI
Benepali 50 mg
4
693.89
771.05
10 %
Injection solution in prefilled syringe: Etanerceptum 50 mg/ml
Samsung Bioepis CH
GmbH
B / SL
FB
G
L
IP
Benepali 25 mg
4
368.63
417.30
10 %
Injection solution in prefilled syringe: Etanerceptum 25mg / 0.5ml
Samsung Bioepis CH
GmbH
B / SL
FB
G
L
IP
Truxima 500 mg/50 ml
1051.32
1159.80
10 %
Concentrate for infusion: Rituximabum 500mg / 50ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Truxima 100 mg/10 ml
2
421.97
475.35
10 %
Concentrate for infusion: Rituximabum 100mg / 10ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
CI
Lynparza 100 mg
112
4585.23
5003.15
10 %
Coated tablets: Olaparibum 100 mg
AstraZeneca AG
A / SL
FB
G
L
IP
Lynparza 150 mg
112
4585.23
5003.15
10 %
Coated tablets: Olaparibum 150 mg
AstraZeneca AG
A / SL
FB
G
L
IP
CI
Trelegy Ellipta
30
64.92
87.00
10 %
Einzeldosiertes Pulver zur Inhalation: 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Trelegy Ellipta
3 x 30
194.75
228.20
10 %
Einzeldosiertes Pulver zur Inhalation: 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Benepali 50 mg
2
368.63
417.30
10 %
Injektionslösung im Fertigpen: Etanerceptum 50 mg/ml
Samsung Bioepis CH
GmbH
B / SL
FB
G
L
IP
CI
Benepali 50 mg
4
693.89
771.05
10 %
Injektionslösung im Fertigpen: Etanerceptum 50 mg/ml
Samsung Bioepis CH
GmbH
B / SL
FB
G
IP
CI
Oxervate
7
PR
PR
k.A.
Eye drops: Cenegerminum
Dompé International SA
B
FB
G
IP
CI
CM
SUN STORE Acetylcystein 600
14
PR
PR
k.A.
Effervescent tablets: Acetylcysteinum 600 mg
Sun Store Health Care AG
D
FB
G
IP
Benepali 25 mg
8
PR
PR
k.A.
Injection solution in prefilled syringe: Etanerceptum 25mg / 0.5ml
Samsung Bioepis CH
GmbH
B
FB
G
IP
CI
BronchostopDUO
Hustenpastillen
20
PR
PR
k.A.
Pastilles: 2 Active Agents
Hänseler AG
D
FB
G
IP
CI
BronchostopDUO
Hustenpastillen
40
PR
PR
k.A.
Pastilles: 2 Active Agents
Hänseler AG
D
FB
G
IP
Irinotecan Accord 1000
mg/50 ml
PR
PR
k.A.
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 1000mg / 50ml
Accord Healthcare AG
A
FB
G
IP
CI
CM
SUN STORE Bisacodyl 5mg
30
PR
PR
k.A.
Dragées: Bisacodylum 5 mg
Sun Store Health Care AG
D
FB
G
IP
CI
Lynparza 100 mg
56
PR
PR
k.A.
Coated tablets: Olaparibum 100 mg
AstraZeneca AG
A
FB
G
IP
Lynparza 150 mg
56
PR
PR
k.A.
Coated tablets: Olaparibum 150 mg
AstraZeneca AG
A
FB
G
IP
CI
CM
SUN STORE Loperamid 2 mg
20
PR
PR
k.A.
Capsules: Loperamidi Hydrochloridum 2 mg
Sun Store Health Care AG
D
FB
G
IP
Noradrenalin Sintetica
0.06 mg/ml
50 ml
PR
PR
k.A.
soluzione per infusione: Noradrenalinum
Sintetica SA
B
FB
G
IP
Noradrenalin Sintetica
0.10 mg/ml
50 ml
PR
PR
k.A.
soluzione per infusione: Noradrenalinum
Sintetica SA
B
FB
G
IP
Noradrenalin Sintetica
0.12 mg/ml
50 ml
PR
PR
k.A.
soluzione per infusione: Noradrenalinum
Sintetica SA
B
FB
G
IP
Noradrenalin Sintetica
0.20 mg/ml
50 ml
PR
PR
k.A.
soluzione per infusione: Noradrenalinum
Sintetica SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home